Exela Technologies Further Expands Relationship with Large Healthcare Member Engagement Leader
Exela Technologies announced an expanded strategic partnership valued at approximately $8 million to enhance its technology and operations solutions within the healthcare sector. This partnership is part of Exela's Healthcare Solutions business, which generated $218 million in revenue in 2021. The deployment of Exela’s PCH Global Cloud Platform aims to enhance consumer engagement and care coordination across various healthcare organizations.
- Expanded partnership valued at approximately $8 million.
- Healthcare Solutions business generated $218 million in revenue in 2021.
- Implementation of advanced healthcare technology, including robotic process automation and machine learning.
- None.
- Exela will provide technology and operation solutions in total contract value of ~
$8 million - Exela’s PCH Global Cloud Platform continues to connect members in multiple healthcare organizations, health insurers and US government programs
IRVING, Texas, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. (“Exela” or “the Company”) (NASDAQ: XELA, XELAP), today announced an expanded strategic partnership to utilize Exela’s technology and operations solutions valued at total contract value of ~
The company’s solution utilizes PCH Global to enhance consumer engagement, drive preventative care and improve the health care user experience. Exela continues to be on the forefront of healthcare technology including advances in robotic process automation, engagement optimization and machine learning. The partnership connects members in many healthcare organizations, health insurers and US government programs.
Exela continues to invest in expanding PCH Global capabilities to provide a cloud hosted solution for communication between a growing number of constituents in the healthcare industry. This expansion of the deployment marks another milestone in the value proposition of PCH Global in healthcare to digitally connect members, providers and insurance companies for member engagement, care coordination and cost of care management.
“In q4 of 2021, we deployed PCH Global for our customer and we are proud to announce that after a successful engagement we will be offering more solutions to that customer enabling additional network effects of the platform for all PCH Global participants,” said Suresh Yannamani, CEO of Exela Technologies BPA, LLC.
About Exela Technologies
Exela Technologies is a business process automation (BPA) leader, leveraging a global footprint and proprietary technology to provide digital transformation solutions enhancing quality, productivity, and end-user experience. With decades of experience operating mission-critical processes, Exela serves a growing roster of more than 4,000 customers throughout 50 countries, including over
For more Exela news, commentary, and industry perspectives, visit: https://investors.exelatech.com/
And please follow us on social:
Twitter: https://twitter.com/exelatech
LinkedIn: https://www.linkedin.com/company/exela-technologies
Facebook: https://www.facebook.com/exelatechnologies/
Instagram: https://www.instagram.com/exelatechnologies
The information posted on the Company's website and/or via its social media accounts may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website and its social media accounts in addition to the Company's press releases, SEC filings and public conference calls and webcasts.
Forward-Looking Statements
Certain statements included in this press release are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "may", "should", "would", "plan", "intend", "anticipate", "believe", "estimate", "predict", "potential", "seem", "seek", "continue", "future", "will", "expect", "outlook" or other similar words, phrases or expressions. These forward-looking statements include statements regarding our industry, future events, estimated or anticipated future results and benefits, future opportunities for Exela, and other statements that are not historical facts. These statements are based on the current expectations of Exela management and are not predictions of actual performance. These statements are subject to a number of risks and uncertainties, including without limitation those discussed under the heading "Risk Factors" in Exela's Annual Report and other securities filings. In addition, forward-looking statements provide Exela's expectations, plans or forecasts of future events and views as of the date of this communication. Exela anticipates that subsequent events and developments will cause Exela's assessments to change. These forward-looking statements should not be relied upon as representing Exela's assessments as of any date subsequent to the date of this press release.
Investor and/or Media Contacts:
Vincent Kondaveeti
E: vincent.kondaveeti@exelatech.com
Mary Beth Benjamin
E: IR@exelatech.com
FAQ
What is the value of Exela's new partnership announced on September 28, 2022?
How much revenue did Exela's Healthcare Solutions business generate in 2021?
What is the purpose of Exela's PCH Global Cloud Platform?
What technologies does Exela utilize in its healthcare solutions?
